Cargando…
An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
Background: Cuproptosis is a newly defined form of cell death, whether cuproptosis involved in hepatocellular carcinoma (HCC) remains elusive. Method: We obtained patients’ RNA expression data and follow-up information from University of California Santa Cruz (UCSC) and The Cancer Genome Atlas (TCGA...
Autores principales: | Chen, Xilang, Sun, Mengyu, Feng, Weibo, Chen, Jie, Ji, Xiaoyu, Xie, Meng, Huang, Wenjie, Chen, Xiaoping, Zhang, Bixiang, Nie, Yongzhan, Fan, Daiming, Wu, Kaichun, Xia, Limin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950118/ https://www.ncbi.nlm.nih.gov/pubmed/36845390 http://dx.doi.org/10.3389/fgene.2023.1056000 |
Ejemplares similares
-
LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
por: Qi, Shiyuan, et al.
Publicado: (2023) -
Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023) -
HMGB1-mediated elevation of KLF7 facilitates hepatocellular carcinoma progression and metastasis through upregulating TLR4 and PTK2
por: Feng, Weibo, et al.
Publicado: (2023) -
Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
por: Shi, Yinli, et al.
Publicado: (2023) -
A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
por: Zhou, Zheng, et al.
Publicado: (2023)